Edge Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Edge Advisors's ELV Position: Q2 2018 in Review
Edge Advisors reduced its Elevance Health (ELV) stake by 38% in Q2 2018, selling an estimated $130K and leaving 923 shares worth $218K. The position accounts for 0.02% of the portfolio, ranked #300.
Edge Advisors first reported a position in ELV in Q4 2016 and has held it in 7 quarters since. The position peaked at $630K in Q4 2016. 934 funds tracked by Wall St. Rank hold ELV as of Q2 2018.
- Edge Advisors held 923 shares of Elevance Health worth $218K as of Q2 2018.
- Edge Advisors sold 561 Elevance Health shares in Q2 2018, an estimated $130K.
- Elevance Health made up 0.02% of Edge Advisors's portfolio in Q2 2018, its #300 holding.
- Edge Advisors first reported a position in Elevance Health in Q4 2016 and has held it in 7 quarters since.
- Edge Advisors's Elevance Health position peaked at $630K in Q4 2016.
- 934 funds tracked by Wall St. Rank held Elevance Health as of Q2 2018.
Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.